TC
ABBV icon

Titleist Capital’s AbbVie ABBV Stock Holding History

Titleist Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$877K Sell
5,427
-75
-1% -$11.5K 0.21% 106
2022
Q3 		$738K Sell
5,502
-39
-0.7% -$5.6K 0.17% 108
2022
Q2 		$849K Sell
5,541
-175
-3% -$26.7K 0.21% 101
2022
Q1 		$927K Buy
5,716
+299
+6% +$43.4K 0.18% 100
2021
Q4 		$733K Buy
+5,417
New +$640K 0.14% 108

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Titleist Capital's ABBV Position: Q4 2022 in Review

Titleist Capital reduced its AbbVie (ABBV) stake by 1.4% in Q4 2022, selling an estimated $11.5K and leaving 5,427 shares worth $877K. The position accounts for 0.21% of the portfolio, ranked #106.

Titleist Capital first reported a position in ABBV in Q4 2021 and has held it in 5 quarters since. The position peaked at $927K in Q1 2022. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Titleist Capital held 5,427 shares of AbbVie worth $877K as of Q4 2022.
  • Titleist Capital sold 75 AbbVie shares in Q4 2022, an estimated $11.5K.
  • AbbVie made up 0.21% of Titleist Capital's portfolio in Q4 2022, its #106 holding.
  • Titleist Capital first reported a position in AbbVie in Q4 2021 and has held it in 5 quarters since.
  • Titleist Capital's AbbVie position peaked at $927K in Q1 2022.
  • 3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.